The Hebel Consulting Group is a global company providing consulting services for the biopharmaceutical industry supported by offices in the US and Germany.
We create a unique process for each client to ensure that business objectives are met and success is achieved.
  • 22 Wingreen Loop, The Hills, TX 78738. USA
  • (713)857-4103
  • (281)-799-3283
  • info@hebelconsulting.com
ebola
from Pharmatimes by Kevin Grogan The European Commission and the European pharmaceutical industry have linked up to launch a 280 million euro call for proposals under the Innovative Medicines Initiative to boost Ebola research. The funding will cover “urgent actions addressing the current epidemic and put in place a long-term strategy to manage any future […]
Read More
Hebel Consulting
AstraZeneca announced that MedImmune, its global biologics research and development arm, has entered into a clinical study collaboration with biopharmaceutical company Incyte Corporation. The Phase I/II oncology study will evaluate the efficacy and safety of MedImmune’s investigational anti-PD-L1 immune checkpoint inhibitor, MEDI4736, in combination with Incyte’s oral indoleamine dioxygenase-1 (IDO1) inhibitor, INCB24360. Both MEDI4736 and […]
Read More